The industry's evolving, so are we

Article

Sometimes I sit back and think about how this magazine has evolved over the years and, on a more regular basis, I think about where we can go from here.

Sometimes I sit back and think about how this magazine has evolved over the years and, on a more regular basis, I think about where we can go from here.

I often call upon the advice of our esteemed Editorial Advisory Board members to guide the editorial direction of this magazine; however, the thoughts of our readers are also of paramount importance. As such, I am incredibly grateful to you for your involvement in readership surveys and for the comments I have received from you by E-mail and at congresses. This really has helped us to serve you better.

As the ophthalmology industry evolves, so too do your needs and as such, we want to make sure that we are providing you with exactly what you want, when you want it.

This is just one example of some of the changes that we are making. Please do keep your suggestions coming because we are listening and every one of your opinions and ideas is taken on board. Ultimately, Ophthalmology Times Europe is your information source so make sure it's perfect for you.

Best wishes,

Fedra Pavlou
Editor
fpavlou@advanstar.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.